A small, obscure biotech just won big with their IPO. In this market. Are you kidding me?
How could a small, largely unknown biotech that emerged from stealth mode just months ago with early-stage cancer programs jump onto Wall Street in the …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
